Bio-Techne (TECH) Dividend Coverage Ratio Growth (5y) (2014 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) Dividend Coverage Ratio Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.45% |
| Mar 31, 2026 | 2.25% |
| Dec 31, 2025 | -3.93% |
| Sep 30, 2025 | 2.54% |
| Jun 30, 2025 | -25.85% |
| Mar 31, 2025 | -9.56% |
| Dec 31, 2024 | -22.52% |
| Sep 30, 2024 | 17.48% |
| Jun 30, 2024 | -30.00% |
| Mar 31, 2024 | 1.09% |
| Dec 31, 2023 | 8.52% |
| Sep 30, 2023 | 22.81% |
| Jun 30, 2023 | 65.36% |
| Mar 31, 2023 | 27.67% |
| Dec 31, 2022 | -0.46% |
| Sep 30, 2022 | 40.07% |
| Jun 30, 2022 | 20.09% |
| Mar 31, 2022 | 20.84% |
| Dec 31, 2021 | 55.74% |
| Sep 30, 2021 | 28.45% |